Company page

Nanobiotix Sa

Nanobiotix Sa, traded under the ticker NANO, is a public company based in France with a market capitalization of approximately €1.99 billion. The company focuses on innovative cancer treatments using nanotechnology. Their approach aims to enhance the effectiveness of radiotherapy and improve patient outcomes.

NANO:EURONEXTUpdated August 28, 2026
Nanobiotix Sa logo
Ticker
NANO:EURONEXT
Asset type
Stock
Market cap
$2.28B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
EURONEXT
Currency
EUR